ORALANCE PHARMA has a total of 16 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals are EXODOS LIFE SCIENCES LTD PARTNERSHIP, COLUMBIA LABORATORIES BERMUDA LTD and SEMNUR PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Republic of Korea | 2 | |
#5 | Mexico | 2 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | France | 1 | |
#9 | Israel | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ioualalen Karim | 12 |
#2 | Raynal Rosanne | 7 |
#3 | Raynal Rose Anne | 6 |
#4 | Lassu Nelly | 3 |
#5 | Brun-Baronnat Christophe | 2 |
#6 | Brun Baronnat Christophe | 1 |
#7 | Ioulalen Karim | 1 |
#8 | Karim Ioualalen | 1 |
#9 | Vassal Gilles | 1 |
#10 | Paci Angelo | 1 |
Publication | Filing date | Title |
---|---|---|
FR2935270A1 | Galenic form under the form of solid lipid particles, useful in pediatrics, comprise temozolomide in lipid matrix, where the matrix comprises triglycerides with saturated fatty acids, and a mixture of fatty acids with specific fatty acids | |
WO2008125423A1 | Non-ionizable hydrophobic galenical system | |
AU2005321182A1 | Novel galenic system for active principle transport, preparation method and use |